2-Oct-2026
Biggest stock movers Thursday: ACN, INGN, and more
Seeking Alpha News (Thu, 1-Oct 10:23 AM ET)
At a glance: stocks gapping up premarket
Seeking Alpha News (Thu, 1-Oct 6:50 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Inogen (INGN), Jade Biosciences (JBIO)
TipRanks (Thu, 1-Oct 6:20 AM ET)
Biggest stock movers Thursday: GOOG, INGN, and more
Seeking Alpha News (Thu, 1-Oct 5:37 AM ET)
Inogen Streamlines Operations With Major Asset Divestiture
TipRanks (Wed, 30-Sep 4:31 PM ET)
Inogen agrees to divest U.S. oxygen rental business to Rotech for up to $25M
Seeking Alpha News (Wed, 30-Sep 4:24 PM ET)
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
Business Wire (Wed, 30-Sep 4:05 PM ET)
Inogen Announces Second Quarter 2026 Financial Results
Business Wire (Thu, 6-Aug 4:05 PM ET)
Globe Newswire (Mon, 3-Aug 4:20 PM ET)
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Wire (Thu, 16-Jul 8:30 AM ET)
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Inogen trades on the NASDAQ stock market under the symbol INGN.
As of October 2, 2026, INGN stock price declined to $5.97 with 413,685 million shares trading.
INGN has a beta of 0.58, meaning it tends to be less sensitive to market movements. INGN has a correlation of 0.04 to the broad based SPY ETF.
INGN has a market cap of $158.43 million. This is considered a Micro Cap stock.
Last quarter Inogen reported $95 million in Revenue and $.00 earnings per share. This fell short of revenue expectation by $-36,000 and exceeded earnings estimates by $.08.
In the last 3 years, INGN traded as high as $13.33 and as low as $4.13.
The top ETF exchange traded funds that INGN belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
INGN has underperformed the market in the last year with a return of -30.0%, while the SPY ETF gained +16.1%. In the last 3 month period, INGN fell short of the market, returning -9.5%, while SPY returned +3.6%. However, in the most recent 2 weeks INGN has outperformed the stock market by returning +16.1%, while SPY returned +1.0%.
INGN support price is $5.82 and resistance is $6.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INGN shares will trade within this expected range on the day.